- Prism Media Wirepodcast

BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025  

Monday, March 30, 2026Thomas WolffView original

The Company continues its progression towards a Nasdaq uplisting POMPANO BEACH, FL, March 30, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that it has filed its […]

The post BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025   first appeared on Prism Media Wire.